Which has grown faster, IQV or MRNA?

Over the past five years, MRNA grew revenue faster — IQV at a 5.61% CAGR versus MRNA at 19.33%.

Is IQV or MRNA more profitable?

IQV runs the higher net margin — IQV at 8.10% versus MRNA at -141.43%.

How have IQV and MRNA total returns compared?

Over the past 5 years, IQV delivered 13.22% and MRNA delivered -17.63% annualized total return. Past performance doesn't predict future results.

IQVIA Holdings Inc. (IQV) vs Moderna, Inc. (MRNA)

A side-by-side comparison of IQVIA Holdings Inc. and Moderna, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 23, 2026. Differences are shown without an overall score or investment verdict.

IQV

IQVIA Holdings Inc.

$42.77B

$259.82HealthcareAt close: Aug 21, 2026, 4:00 PM ET

MRNA

Moderna, Inc.

$57.59B

$145.13HealthcareAt close: Aug 21, 2026, 4:00 PM ET

Total return — IQV vs MRNA

growth of $100 · dividends reinvested · last 8y

IQV +111.0% (+9.8%/yr)MRNA +680.3% (+29.3%/yr)MRNA compounded faster over this window

IQV MRNA

IQV vs MRNA: by the numbers

•MRNA is the larger company ($57.59B vs $42.77B market cap).
•IQV is profitable (8.10% net margin) while MRNA runs a net loss (-141.43%).
•MRNA grew revenue faster over the past five years (19.33% vs 5.61% CAGR).

Metrics side by side

Valuation

Metric	IQV	MRNA
P/E ratio	32.24	N/A
Forward P/E	20.04	N/A
P/S ratio	2.58	25.80
P/B ratio	7.10	8.50
EV / EBITDA	16.67	N/A
FCF yield	5.97%	N/A

Profitability

Metric	IQV	MRNA
Gross margin	26.23%	55.35%
Operating margin	13.57%	-158.13%
Net margin	8.10%	-141.43%
ROE	22.28%	-46.61%
ROIC	8.32%	-39.16%

Growth (annualized)

Metric	IQV	MRNA
Revenue CAGR (5Y)	5.61%	19.33%
EPS CAGR (5Y)	40.21%	N/A
FCF CAGR (5Y)	4.44%	N/A
Total return CAGR (5Y)	0.40%	-17.63%

Frequently asked

Which has grown faster, IQV or MRNA?: Over the past five years, MRNA grew revenue faster — IQV at a 5.61% CAGR versus MRNA at 19.33%.
Is IQV or MRNA more profitable?: IQV runs the higher net margin — IQV at 8.10% versus MRNA at -141.43%.
How have IQV and MRNA total returns compared?: Over the past 5 years, IQV delivered 13.22% and MRNA delivered -17.63% annualized total return. Past performance doesn't predict future results.

Go deeper

Full IQV analysis Full MRNA analysis Interactive comparison tool

Dig into the metrics

IQVIA P/E ratio IQVIA ROE Moderna ROE IQVIA operating margin Moderna operating margin IQVIA revenue growth Moderna revenue growth IQVIA free cash flow Moderna free cash flow

IQVIA & Moderna appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 23, 2026.